Legacy Wealth Asset Management LLC Sells 20,779 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)

Legacy Wealth Asset Management LLC lessened its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK) by 12.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 140,837 shares of the company’s stock after selling 20,779 shares during the quarter. Legacy Wealth Asset Management LLC’s holdings in Takeda Pharmaceutical were worth $1,865,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the company. Millennium Management LLC boosted its holdings in Takeda Pharmaceutical by 87.1% in the second quarter. Millennium Management LLC now owns 4,346,151 shares of the company’s stock worth $56,239,000 after acquiring an additional 2,023,707 shares in the last quarter. FMR LLC lifted its holdings in shares of Takeda Pharmaceutical by 10.9% in the 3rd quarter. FMR LLC now owns 2,908,918 shares of the company’s stock worth $41,365,000 after purchasing an additional 286,052 shares in the last quarter. Van ECK Associates Corp grew its position in Takeda Pharmaceutical by 6.6% in the 3rd quarter. Van ECK Associates Corp now owns 2,175,236 shares of the company’s stock valued at $30,149,000 after purchasing an additional 134,407 shares during the period. Managed Asset Portfolios LLC increased its stake in Takeda Pharmaceutical by 0.3% during the 3rd quarter. Managed Asset Portfolios LLC now owns 1,617,541 shares of the company’s stock valued at $23,001,000 after purchasing an additional 4,069 shares in the last quarter. Finally, Stifel Financial Corp raised its holdings in Takeda Pharmaceutical by 103.9% during the third quarter. Stifel Financial Corp now owns 440,666 shares of the company’s stock worth $6,266,000 after buying an additional 224,594 shares during the last quarter. 9.17% of the stock is currently owned by institutional investors and hedge funds.

Takeda Pharmaceutical Stock Down 0.4 %

Takeda Pharmaceutical stock opened at $13.05 on Friday. The company has a current ratio of 1.28, a quick ratio of 0.77 and a debt-to-equity ratio of 0.64. The firm’s fifty day moving average price is $13.40 and its two-hundred day moving average price is $13.89. The firm has a market capitalization of $41.51 billion, a price-to-earnings ratio of 22.49, a price-to-earnings-growth ratio of 0.23 and a beta of 0.51. Takeda Pharmaceutical Company Limited has a 1-year low of $12.57 and a 1-year high of $15.08.

Takeda Pharmaceutical Company Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.